Ipamorelin, a pentapeptide, is a growth hormone-releasing peptide (GHRP) that stimulates the pituitary gland to release growth hormone. It is often investigated for its potential to increase growth hormone levels without significantly affecting cortisol or prolactin levels, unlike some other GHRPs. Research contexts involving this peptide have explored potential impacts on muscle growth, fat reduction, and overall well-being.
The interest in growth hormone-releasing peptides stems from a desire to leverage the body’s natural mechanisms for producing growth hormone. Elevated growth hormone levels have been associated with improved body composition, enhanced recovery from exercise, and potential anti-aging effects. Historically, the focus has been on understanding how these peptides interact with the growth hormone secretagogue receptor and the subsequent physiological responses.
